The Advisory Team at PrimeVax Immuno-Oncology comprises a diverse group of business and scientific experts who provide strategic guidance and insights to drive the development of innovative cancer treatments. They collaborate to assess market trends, shape clinical strategies, and enhance the company's scientific approaches, ensuring that PrimeVax remains at the forefront of immuno-oncology advancements.
Alessandra Cesano
Scientific Advisor
Bernard Fox
Scientific Advisor
Bob Battista
Business Advisor
Carlo Bifulco
Scientific Advisor
Ena Wang
Scientific Advisor
Franco Marincola
Scientific Advisor
Joyson Karakunnel
Scientific Advisor
Nina Bhardwaj
Scientific Advisor
Paolo Ascierto
Scientific Advisor
Stephen Thomas
Scientific Advisor